
|Videos|November 25, 2015
Q&A With Marco Carbone From University of Cambridge: Developing A Scoring System To Predict Primary Biliary Cholangitis
Author(s)Adam Hochron
When treating liver disease every advantage can help doctors get their patients the care they need before the condition progresses further. A recent study looked at the potential of developing a scoring system to look at risks for this patient population.
Advertisement
When treating liver disease every advantage can help doctors get their patients the care they need before the condition progresses further. A recent study looked at the potential of developing a scoring system to look at risks for this patient population.
Marco Carbone, MD, from the University of Cambridge discussed why the system was being developed and what it could mean to patient care during the annual Liver Meeting in San Francisco.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
OMA 2026 Recap: Pediatrics, Retention, and Lifestyle Changes in Obesity
2
A Real-World Case: Initiating Ritlecitinib After Years of Untreated Disease
3
Choosing Among Approved JAK Inhibitors: Baricitinib, Ritlecitinib, and Deuruxolitinib
4
Red Flags for Misdiagnosed Type 2, When to Order Antibodies and C‑Peptide
5




































































